factory visit - report, page-5

There is a little bit there in the report but I pushed that he needs to produce this sometime in the future. I'm sure everybody (share holders, institutions, analysts) confidence would lift big time. I think if he has say 80, 100, 150M/yr revenue lock in for year after year then he should be able to give some guidelines on the other products.

Just a side issue - say in the pumps one drug may need 3 months to do a trial and another might need 12 mths. So he can't be too specific on things.